GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, swelling that can be caused by cancer treatment.

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Researchers used data from more than 92,000 people with type 2 diabetes. They found that two medications significantly ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...

A WOMAN has revealed that she lost over seven stone after using Mounjaro.  Katy, a 37-year-old from Southampton, was able to ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...

Our government should be in the business of making lifesaving medication accessible and affordable. The Trump administration ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...

Finding natural ways to increase glucagon-like peptide-1, otherwise known as GLP-1, can be very beneficial in helping treat type 2 diabetes and obesity.